Your browser doesn't support javascript.
loading
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile.
Zhao, Qingnan; Hu, Jiemiao; Mitra, Abhisek; Cutrera, Jeffry; Zhang, Wendong; Zhang, Zhongting; Yan, Jun; Xia, Xueqing; Mahadeo, Kris Michael; Livingston, John Andrew; Gorlick, Richard; Li, Shulin.
Afiliação
  • Zhao Q; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Hu J; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Mitra A; Pharmaceutical company of Pfizer in Pearl River, New York, NY, 10965, USA.
  • Cutrera J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhang W; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhang Z; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Yan J; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Xia X; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Mahadeo KM; Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Gorlick R; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Li S; Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Sli4@mdanderson.org.
J Immunother Cancer ; 7(1): 154, 2019 06 17.
Article em En | MEDLINE | ID: mdl-31208461

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-12 / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-12 / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido